Mason-Pfizer monkey virus (M-PMV) represents the prototype type D retrovirus, characterized by the assembly of intracytoplasmic A-type particles within the infected-cell cytoplasm. These immature particles migrate to the plasma membrane, where they are released by budding. Thegag gene of M-PMV encodes a novel protein, p12, just 5' of the major capsid protein (CA) p27 on the polyprotein precursor. The function of p12 is not known, but an equivalent protein is found in mouse mammary tumor virus and is absent from the type C retroviruses. In order to determine whether the p12 protein plays a role in the intracytoplasmic assembly of capsids, a series of in-frame deletion mutations were constructed in the p12 coding domain. The mutant gag genes were expressed by a recombinant vaccinia virus-T7 polymerase-based system in CV-1 cells or in the context of the viral genome in COS-1 cells. In both of these high-level expression systems, mutant Gag precursors were competent to assemble but were not infectious. The genomic organization of M-PMV is similar to that of most noncomplex retroviruses, with four genes in the order 5'-gag-pro-pol-env-3' (21). The gag gene products are synthesized as a polyprotein precursor, Pr78, which is cleaved proteolytically during maturation to yield the individual virion proteins, which are arranged in the order NH2-p1O (MA)-pp24/ppl8-pl2-p27 (CA)-p14 (NC)-p4-COOH. The function of the phosphoproteins p12 and p4 is not known.
is not known, but an equivalent protein is found in mouse mammary tumor virus and is absent from the type C retroviruses. In order to determine whether the p12 protein plays a role in the intracytoplasmic assembly of capsids, a series of in-frame deletion mutations were constructed in the p12 coding domain. The mutant gag genes were expressed by a recombinant vaccinia virus-T7 polymerase-based system in CV-1 cells or in the context of the viral genome in COS-1 cells. In both of these high-level expression systems, mutant Gag precursors were competent to assemble but were not infectious. In contrast, when stable transfectant HeLa cell lines were established, assembly of the mutant precursors into capsids was drastically reduced. Instead, the polyprotein precursors remained predominantly soluble in the cytoplasm. These results show that while p12 is not required for the intracytoplasmic assembly of M-PMV capsids, under the conditions of low-level protein biosynthesis seen in virus-infected cells, it may assist in the stable association of polyprotein precursors for capsid assembly. Moreover, the presence of the p12 coding domain is absolutely required for the infectivity of M-PMV virions.
Mason-Pfizer monkey virus (M-PMV) was the first retrovirus to be isolated from a nonhuman primate and was recovered from an 8-year-old female rhesus macaque (Macaca mulatta) in 1970 (5, 10) . Subsequent studies re- vealed that this virus, although isolated from a mammary adenocarcinoma, was not oncogenic; instead, infected macaques suffered a severe immunosuppressive disease with a pathology distinct from that associated with the lentiviruses simian immunodeficiency virus and human immunodeficiency virus (3) . M-PMV represented a new group of RNA tumor virus, type D, which could be distinguished morphologically from both type C and type B retroviruses. The type D group, like the type B viruses, is characterized by the preassembly of intracytoplasmic A-type particles (ICAPs) that migrate to the plasma membrane and are released by budding. The virion can be distinguished from the mature type B virus, however, since the latter has a much denser array of surface projections. Type C retroviruses, in contrast, both assemble their capsids and bud simultaneously from the plasma membrane.
The genomic organization of M-PMV is similar to that of most noncomplex retroviruses, with four genes in the order 5'-gag-pro-pol-env-3' (21) . The gag gene products are synthesized as a polyprotein precursor, Pr78, which is cleaved proteolytically during maturation to yield the individual virion proteins, which are arranged in the order NH2-p1O (MA)-pp24/ppl8-pl2-p27 (CA)-p14 (NC)-p4-COOH. The function of the phosphoproteins p12 and p4 is not known.
Type B viruses, the prototype of which is mouse mammary tumor virus (MMTV), also preassemble ICAPs and also have an additional cleavage product that is located N-terminal to the major capsid protein, p3-p8-n, where n represents 17 amino acids not found as a cleavage product on protein purification but present in the viral sequence (9, 12) . The p3-p8-n polypeptide, although cleaved into these minor peptides, comprises a region of 74 amino acids similar to the p12 protein of M-PMV, which is 83 amino acids long (21) . The endogenous type D virus squirrel monkey retrovirus, which also preassembles ICAPs, does not contain p12 as a proteolytic cleavage product; instead, the major capsid protein of 35 kDa is antigenically cross-reactive with the M-PMV p27 (CA) (1, 7) and may represent a fusion between the p12 and p27 proteins. Both the p12 and the MMTV p3 product have N termini that contain many acidic residues (Fig. 1 (2) . COS-1 cells transfected with each mutant genome were analyzed by pulse-chase immunoprecipitation as above at 48 h after transfection, except that a 4-h chase period and either goat anti-M-PMV or rabbit anti-p27 polyclonal antiserum were used.
RT assay. Infected and mock-infected cell culture supernatants (3-ml volumes) were clarified by centrifugation at 8,000 rpm for 20 min in a Beckman J21 centrifuge. Virus was pelleted from the resultant supernatant by centrifugation at 80,000 rpm for 15 min in a TL100 Beckman tabletop centrifuge and used for the reverse transcriptase (RT) assay as described previously (18) .
Infectivity assays. The clarified culture medium from COS-1 cells that had been transfected 48 h previously with each mutant was used as the source of virus. An RT assay was performed, and equivalent amounts of RT activity were used to inoculate human HOS cells that had been seeded the day before as described previously (20) . The cells were maintained for 21 days postinfection, medium being collected every fourth day, when the cells were passaged.
Following clarification at 8,000 rpm for 20 min, the samples were stored at -100°C until analyzed by the RT assay.
Electron microscopy. HOS, CV-1, and COS-1 cells, trans-I fected with and expressing each mutant, were fixed in gluteraldehyde and postfixed with osmium tetroxide. The samples were then dehydrated and embedded in Epon. Ultrathin sections were stained with uranyl acetate and lead citrate as described previously (20) .
Determining the kinetics of virus assembly in HeLa cells. To determine the proportion of polyprotein precursors that were assembled over time into ICAPs, HeLa cells stably transfected with each mutant were lysed in Triton X-100 buffer after being pulse labeled, as described previously (18) . Assembled ICAPs in Triton buffer were pelleted at 80,000 rpm, while precursors that were not assembled remained in the supernatant fraction. The proportion of precursors that assembled into ICAPs was monitored at 1, 2, and 4 h postlabeling with [3H]leucine. The pelletable and supernatant fractions were immunoprecipitated with a rabbit antip27 polyclonal antiserum. RESULTS Generation of in-frame p12 deletion mutations. An additional proteolytic cleavage product from the Gag polyprotein precursor is found in both M-PMV (a type D retrovirus) and MMTV (a type B retrovirus), both of which preassemble ICAPs. The protein sequences of these additional cleavage products were compared (Fig. 1) . It is evident that they are similar in size (although the MMTV product is subsequently cleaved into smaller peptides) and show a cluster of acidic amino acid residues at the N terminus. A series of in-frame deletions were constructed in the M-PMV p12 coding domain, as illustrated in Fig. 2 . After these mutations were inserted into the full-length infectious molecular clone of M-PMV and into a vaccinia virus-T7 expression system, the effects of these deletions on M-PMV morphogenesis and infectivity were analyzed.
Assembly of p12 deletion mutants expressed in the vaccinia virus-T7 expression system in CV-1 cells. The p12 deletion mutants were cloned into the pSP72 vector carrying the M-PMV gag and pro genes under the control of the T7 promoter and transfected into CV-1 cells preinfected with recombinant vaccinia virus expressing the T7 polymerase gene. The T7 polymerase enzyme expressed from vaccinia virus provided a transient high-level expression of M-PMV. As shown in Fig. 3 , intracytoplasmic capsids indistinguishable from those of the wild-type construct were assembled, indicating that all of the p12 deletion mutants were competent to assemble particles. These results provided preliminary evidence that the p12 coding domain was not essential for ICAP assembly. Since only Pr78gag and Pr95ragPm°are expressed in this T7 expression system, each mutant was subcloned into the full-length infectious molecular clone of M-PMV, pSHRM15, in which the effect of deletions within the p12 coding domain could be assessed in the context of the viral genome.
Morphogenesis of the M-PMV p12 deletion mutants in COS-1 cells. Following transfection of each mutant into COS-1 cells, the cells were examined by electron microscopy. Figure 3 shows that all the mutants were competent to assemble particles. In contrast to the wild type, however, the mutants A8-58, A1-25, and A26-53 showed a proportion of particles assembling and budding from the plasma membrane. Particles from mutant A1-83, which lacked the entire p12 coding domain, were associated predominantly with intracellular vesicles.
Pulse-chase experiments with COS-1 cells transfected with wild-type pSHRM15 showed that each of the structural protein precursors (Pr78, Pr95, and Prl80) was labeled during the 20-min pulse period (Fig. 4 , WT, lane P). These precursors were then cleaved to the mature virus proteins during the chase. This is evidenced by the appearance of p27, a major antigen recognized by the goat polyclonal antiserum used in this experiment (Fig. 4, WT, lane C) . Particles released into the cell culture supernatants contained p27 (Fig. 4 , WT, lane Sn). For mutants A8-58, A1-25, and A26-53, a proteolytic profile comparable to the wild-type profile was observed (Fig. 4) ; however, for mutants A1-83 and A54-83, no p27 was observed in the chase lysates or supernatant. Instead, a 45-kDa product was found. Both of these mutations bordered the p12-p27 junction (see Fig. 2 ) and resulted in an altered p12-p27 cleavage site that might not be recognized by the viral aspartyl protease. To test this, we repeated the immunoprecipitation with a p27-specific polyclonal antiserum. Figure 5 shows that the p45 product is immunoreactive with the anti-p27 antibody, indicating that it represents a fusion between p27 and pp24/ppl8 (for mutant A1-83) and of p27 with the remainder of p12 (for mutant A54-83).
Infectivity of the p12 deletion mutants. To determine whether the mutant virions released from COS-1 cells were infectious, the culture medium from cells transfected with each mutant was used as a source of virus to infect human HOS cells. Equivalent levels of virus were inoculated onto human HOS cells, and RT activity released into the medium following infection was monitored over time. While infection of HOS cells with virus released from wild-type pSHRM15-transfected cells resulted in high levels of RT activity at the first (8 days postinfection) time point (Fig. 6 ), negligible RT activity was released from cells inoculated with mutant virions. This demonstrates that deletion of any region of the p12 coding domain results in a loss of infectivity.
Pulse-chase immunoprecipitation of HeLa cells transfected with each p12 deletion mutant. Since both the T7-based and COS-1 expression systems result in very high levels of viral protein synthesis, we established stably transfected populations of HeLa cells expressing the wild-type and mutant genomes in order to more accurately mimic the conditions of virus infection. These cell populations were then used to analyze protein expression and capsid assembly. A pulsechase analysis, with an anti-p27 antibody used to immunoprecipitate viral proteins, of HeLa cells expressing each p12 deletion mutant is shown in Fig. 7 . For cells expressing the wild-type genome, the precursors immunoprecipitated from the pulse-labeled cells have been processed after an 8-h chase, and a strong band of cell-associated p27 is evident (Fig. 7 , WT, lanes P and C). In contrast, for each of the N-terminal p12 deletion mutants (A8-58, A1-83, and A1-25), it is evident that following an 8-h chase, there was no detectable p27 or p45, and the polyprotein precursors remained stable. In mutants A26-53 and A54-83, less-intense (compared with the wild type) bands of p27 and p45 could be seen. Furthermore, there was no evidence of virus release from the N-terminal deletion mutant-expressing cells, and only minimal amounts were released from cells expressing mutants A26-53 and A54-83 (data not shown).
Determining the kinetics of ICAP assembly in HeLa cells.
The immunoprecipitation experiments in HeLa cells revealed that proteolytic processing was very inefficient, but these results could not distinguish between precursors that were free in the cytoplasm and those assembled into particles. To determine what proportion of precursors over time were assembled into capsids, we exploited the detergentresistant property of ICAPs, which remain in a stable pelletable form following cell lysis and can be distinguished from unassembled precursors, which cannot be pelleted. The pulse-chase experiment described above was repeated, and cells were lysed at various chase times in Triton X-100 lysis buffer. The pellet and supernatant fractions were then immunoprecipitated separately. Figure 8 shows that after a 1-h chase, most of the wild-type virus precursors synthesized in the pulse were found in the pellet fraction, indicating that they have been assembled into ICAPs. Over time, the precursor proteins were lost from the cell because of virus release. For all mutants except A26-53 and A54-83, all of the precursors remained at a stable level in the supernatant fraction, showing that they remained predominantly unassembled in the cytoplasm. Cells expressing mutants A26-53 and A54-83 did contain a proportion of pelleted precursors, which is consistent with the observation of marginal processing and virus release described above for these mutants.
For most of the N-terminal deletion mutants, a small fraction of pelletable precursors could be found after the 4-h chase. To determine whether these precursors were assem- bling into ICAPs with very low efficiency, the cells were examined by electron microscopy. In each case, a few isolated particles could be seen in the transfected-cell cytoplasm (data not shown). This demonstrates that assembly, although possible, was very inefficient in the HeLa cell populations.
DISCUSSION
Particle assembly represents a late stage in the virus life cycle. For retroviruses, this process can occur in either of two ways. For type B and type D retroviruses, the Gag precursor molecules synthesized on free polysomes in the cytoplasm are subsequently required to associate in the absence of membranes in a manner that leads to stable capsid formation. These preformed particles (ICAPs) then migrate to the plasma membrane, where they are released by budding. Retroviruses that demonstrate type C morphogenesis also synthesize their Gag precursors on free polysomes, but instead of associating at an intracytoplasmic location, the precursor molecules migrate independently to the inner face of the plasma membrane before interacting. In this case, particle formation occurs as the virus simultaneously buds from the cell.
M-PMV provides a very useful model for studying virus assembly because the processes of assembly and budding are unlinked and therefore assembly mechanisms can be studied in isolation. The reason why some retroviruses preassemble ICAPs while others assemble and bud concomitantly from the plasma membrane has been an enigma. Recently, a model was proposed to explain the cytoplasmic assembly of M-PMV following delineation of a signal located within the matrix protein of the newly synthesized precur- To determine what role the p12 protein might play in ICAP assembly, a series of in-frame deletion mutants were generated. The region encompassing the retention signal in the matrix protein was maintained. With the vaccinia virus-T7 expression system (6, 8, 13 ) and a recombinant vector carrying the M-PMV gag and pro genes, wild-type and mutant precursors were shown to be competent to assemble. This demonstrated that the Gag-Pro precursors alone could assemble particles in the absence of the polymerase and envelope genes. Moreover, deleting the entire p12 coding domain did not prevent ICAP assembly.
Expression of these mutant gag genes from the M-PMV genomic vector pSHRM15 in COS-1 cells also allowed virus assembly. However, for some mutants, the site of assembly was altered. Mutants A1-25, A26-53, and A8-58 assembled predominantly at the membrane, typical of type C morphogenesis. Since these mutations involved large deletions, the subsequent alteration of the three-dimensional structure of the precursor may have affected the accessibility of the retention signal in COS-1 cells, leading to type C morphogenesis.
None of the p12 deletion mutant virions released from COS-1 cells proved to be infectious, demonstrating that all regions of the p12 coding domain are required for infectivity. The basis for this lack of infectivity is unclear. For mutants A1-83 and A54-83, the presence of the incomplete cleavage product p45 may contribute to the lack of infectivity, since it has been shown in dose dependence studies with inhibitors of the viral aspartyl protease that complete cleavage of precursors is required to confer infectivity (20) . The remaining mutants all exhibited some level of type C morphogenesis in COS-1 cells, and this might be inconsistent with assembly of infectious virus. The M-PMV mutant described previously that had acquired type C morphogenesis was also noninfectious (15) . This mutation was located in the matrix protein, and the virus failed to efficiently incorporate envelope glycoproteins. As Both the vaccinia virus-T7 system and expression from pSHRM15 in COS-1 cells represent artificially high levels of protein synthesis. For this reason, transfection and stable integration of the viral genome into HeLa cells were also used to study these mutants. Interestingly, in contrast to wild-type virus, mutant precursors were not readily processed into mature products except for mutants A26-54 and A54-83, for which low but detectable levels of p27 and p45, respectively, were observed. This is in agreement with previous observations of mutant A8-58, which, when expressed from the AHin vector in HeLa cell clones, showed stable precursor formation (14) . The stability of these mutant precursors contrasts with that of similar large deletions that were made within the matrix protein of the M-PMV gag gene, which resulted in a rapid degradation of precursors (16) . This led to the hypothesis that the matrix protein played an important role in guiding the correct folding of the Gag polyprotein, which was crucial both for stabilizing the molecule and for facilitating the intermolecular interactions that are involved in ICAP assembly. The p12 domain thus does not appear to play a critical structural role in stabilizing the precursor protein.
When the mutant precursors were analyzed for their ability to assemble into pelletable capsids, only the mutant precursors that showed some proteolytic processing (A26-53 and A54-83) could assemble with any significant efficiency. This suggested that deletions within the C-terminal region of the p12 coding domain allowed inefficient particle formation. The region of the p12 coding domain that was common to the mutants that encoded assembly-defective precursors encompassed amino acids 8 to 25. Figure 1 shows that a large cluster of acidic residues are found in this region in both M-PMV and MMTV. Moreover, structure predictions suggest that this region may represent an acidic face of the molecule and that such a region of negative charge might be important for the stable association of precursors in ICAP formation.
It is evident that the p12 protein of M-PMV plays an essential role in the virus life cycle. This region of the Gag precursor plays a critical role in facilitating the intermolecular interactions necessary for capsid assembly in HeLa cells. Nevertheless, this region appears to be dispensable for assembly when very high levels of protein are expressed within the cytoplasm of the cell. It is unlikely, therefore, that it plays a direct role in the assembly process itself but acts more like a cis-acting catalytic domain during this important phase of the viral replication cycle. As such, the p12 domain appears to play a critical role in type D virus infectivity.
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